VanEck Gold Miners ETF vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? VanEck Gold Miners ETF trades at $88.51 (market cap $25.65B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.28B). The key difference: VanEck Gold Miners ETF is far larger — about 11.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, VanEck Gold Miners ETF nearer its low. Which is the better fit depends on your goals.
| GDX | SLS | |
|---|---|---|
Market Cap | $25.65B | $2.28B |
Volume | 20,709,928 | 3,128,960 |
52-Week High | $115.84 | $15.46 |
52-Week Low | $68.28 | $1.39 |
Typical Hold Time | 76 Days | — |
Sector | — | Health |
Enterprise Value | — | $2.15B |
Signals from Pluang's Aura AI — not financial advice
GDX trades at $85.46, down 3.13% today amid a bearish technical signal with 13 of 13 moving averages indicating sell signals. The ETF faces pressure from rising interest rates impacting dividend stocks and metals, with silver's sharp decline highlighting sector weakness. Recent news notes institutional selling by Allworth Financial and HB Wealth Management, though Ameritas Advisory increased its stake. Support sits at $84-$85, with resistance at $86-$87.
The outlook remains cautious due to bearish technicals and macro headwinds, but some analysts see value in gold miners' low valuations. Key risks include interest rate sensitivity and metals volatility, while potential catalysts include gold price stability and institutional accumulation. Investors should weigh technical weakness against long-term diversification benefits.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.
Read more on GDX →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →